S. aureus Bacteremia: Cloxacillin Dosing Study

We are investigating whether kidney function can help identify patients who may need adjusted doses of cloxacillin. This study aims to ensure safer and more effective treatment for those with S. aureus bacteremia.

Monitoring phase (IV)No PlaceboStandard MedicinesInjectionInfectious DiseasesNephrology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Cloxacillin Auxilia
Cloxacillin Auxilia is an antibiotic used to treat bacterial infections, especially skin and soft tissue infections.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Cloxacillin
Cloxacillin is an antibiotic substance used to treat bacterial infections, especially staph infections resistant to penicillin.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Cloxacillin Xgx Pharma
Cloxacilline Arrow
Cloxacilline Biogaran

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Laenssjukhuset I Kalmar Region Kalmar Laen
Infektionskliniken
Kalmar, Sweden
Region Oestergoetland
Infektionskliniken i Östergötland
Linköping, Sweden
Sponsor: Region Oestergoetland
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.